GlobeNewswire

CUKTECH Makes MPL Malaysia S18 Playoffs Debut to Champion Reliable Power and Peak Performance in Esports
13/11/2026
KUALA LUMPUR, Nov. 13, 2026 (GLOBE NEWSWIRE) -- CUKTECH made its debut at the Mobile Legends: Bang Bang (MLBB) Professional League (MPL) Malaysia Season 18 Playoffs as the league's Strategic Partner for the Powerbank [...]
RAMSAY GENERALE DE SANTE : ASSEMBLEE GENERALE MIXTE DU 4 DECEMBRE 2026
13/11/2026
INFORMATION REGLEMENTAIRE Paris, le 13 novembre 2026 ASSEMBLEE GENERALE MIXTE DU 4 DECEMBRE 2026 Convocation de l’Assemblée Générale Mixte de Ramsay Générale de Santé Modalités de mise à disposition ou de consultation [...]
RAMSAY GENERALE DE SANTE : COMBINED GENERAL MEETING OF DECEMBER 4, 2026
13/11/2026
REGULATORY INFORMATION Paris, 13 November 2026 COMBINED GENERAL MEETING OF DECEMBER 4, 2026 Convening of the Ramsay Générale de Santé General Meeting Conditions of availability and consultation of the preparatory [...]
FREHEMGO® (denecimig) approved in the EU for haemophilia A, with a choice of monthly, every-two-weeks or weekly dosing
13/11/2026
European Commission (EC) grants marketing authorisation for FREHEMGO® (denecimig) for haemophilia A (congenital FVIII deficiency), with or without inhibitors, in adults and children. FREHEMGO® is the first FVIIIa [...]
XORTX Patent Allowed for XRx-101 Program by Japan Patent Office
13/11/2026
Japan Patent Office allows claims directed to xanthine oxidase inhibitor compositions for acute kidney injury and other health consequences of viral infection; once registered, patent expected to remain in force until [...]
HealthEx Joins Sierra’s Personal Agent Protocol as a Design Partner
13/11/2026
HealthEx will help shape how personal AI agents work with healthcare organizations, bringing experience in verified identity, consent, and personal health context SAN FRANCISCO, Nov. 13, 2026 (GLOBE NEWSWIRE) -- [...]
Oncolytics Biotech® Announces Clinical Supply Agreement to Evaluate Pelareorep in Combination with LOQTORZI® (toripalimab-tpzi) in SCAC
13/11/2026
Pelareorep and toripalimab combine potentially complementary mechanisms designed to enhance antitumor immune responses and help overcome tumor immune resistance Study may represent a first step toward evaluating the [...]
Pennant Group to Participate in the 2026 Stephens Annual Investment Conference
13/11/2026
EAGLE, Idaho, Nov. 13, 2026 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, announced today that it [...]
Kura Oncology to Participate in Two Investor Conferences in November
13/11/2026
SAN DIEGO, Nov. 13, 2026 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a biopharmaceutical company focused on precision medicines for the treatment of cancer, today announced that management will present at [...]
From the Fire Service to Counselling; Guelph Clinic Brings Community Experience into Psychotherapy
13/11/2026
Trickett Psychotherapy welcomes four practitioners with backgrounds in addiction support, emergency response, vocational counselling and corporate life, alongside a holiday initiative to make a first session more [...]
Jade Biosciences Reports Third Quarter 2026 Financial Results and Provides Corporate Update
13/11/2026
JADE101 Phase 3 registrational trial in IgA nephropathy (EVERGREEN) expected to initiate in the fourth quarter of 2026 JADE101 Phase 2 clinical trial in IgA nephropathy (JUNIPER) ongoing; interim data expected in the [...]
Tvardi Therapeutics Announces Third Quarter 2026 Results and Provides Business Update
13/11/2026
HOUSTON, Nov. 13, 2026 (GLOBE NEWSWIRE) -- Tvardi Therapeutics, Inc. (“Tvardi” or the “Company”) (NASDAQ: TVRD), a clinical-stage biopharmaceutical company focused on the development of novel, oral, small molecule [...]
BioCryst Presents New Real-World Evidence Showing Reduced Angioedema-Related Medical Visits After Switching to ORLADEYO® (berotralstat) at ACAAI 2026 Annual Scientific Meeting
13/11/2026
— Two real-world studies demonstrate reductions in healthcare resource utilization in HAE patients who initiated or switched to ORLADEYO ® from another prophylactic therapy — RESEARCH TRIANGLE PARK, N.C., Nov. 13, 2026 [...]
Contract Terms Shape How Quickly Outsourced Customer Support Can Scale Down After a Seasonal Spike
13/11/2026
The seat floor is the number of agents a company pays for every month, and it should equal the headcount it runs outside launches and holiday peaks. The notice period decides how early a company has to request a seat [...]
Joint replacement in Charleston: a credentials checklist for choosing an orthopedic surgeon
13/11/2026
Novant Health Orthopedics & Sports Medicine Institute outlines the credentials Charleston-area patients can check before a first visit and the questions to bring to a knee or hip replacement consultation Mount [...]
Milestone Pharmaceuticals Reports Third Quarter 2026 Financial Results and Announces Cost-Efficiency Measures Designed to Extend Cash Runway Through AFib-RVR Phase 3 Data
13/11/2026
Launch of CARDAMYST ® (etripamil) nasal spray marked by steady prescription growth, new prescriber expansion and improving commercial coverage Company is reducing operating expenses by approximately 30% while [...]
Milestone Scientific Reports Financial Results for Third Quarter 2026
13/11/2026
Medical Segment Revenue Grows 136% Year-Over-Year Expands CompuFlo® Physician Partnerships and Advances Medical Commercialization Online Demonstrations More Than Double Reflecting Increased Customer Engagement Reaffirms [...]
GH Research Announces Appointment of Vanina Popova, MD, as Chief Development Officer
13/11/2026
Dr. Popova will lead the clinical development of GH001 as the company advances toward pivotal programs in TRD and PPD Brings more than 20 years of global pharmaceutical R&D experience at Johnson & Johnson across [...]
GH Research Reports Third Quarter 2026 Financial Results and Provides Business Update
13/11/2026
Novel GH001 Aerosol Delivery System (ADS) device: final results of the GH001-HV-106 trial support going from 3 → 1 doses per treatment visit TRD pivotal program — positive initial feedback from FDA, End-of-Phase 2 [...]

Pages

Other news

Test 2

Lorem ipsum

Test 1

Lorem upsum